Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Investigation of Disease Outbreaks

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Spotlight commentary: Deprescribing in long-term care facilities-Towards safer and smarter medication use in older adults.

British journal of clinical pharmacology·2026

Same author

The impact of biological interventions on health-related quality of life in adults with Crohn's disease: a systematic review with meta-analysis.

EClinicalMedicine·2025

Same author

A time series analysis approach to quantify change in antibiotic resistance and antibiotic consumption during COVID-19 epidemics: a multicentre cross-national ecological study on behalf of QUantifying change in Antibiotic Resistance, ANTibiotic use, and INfection control during COVID-19 Epidemics study project.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2025

Same author

Measuring hospital antibiotic consumption in EU/EEA countries: comparison of different metrics, 2017 to 2021.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2024

Same author

Afatinib-induced toxic epidermal necrolysis: A case report with a literature review.

British journal of clinical pharmacology·2024

Same author

The side effect registry immuno-oncology (SERIO) - A tool for systematic analysis of immunotherapy-induced side effects.

European journal of cancer (Oxford, England : 1990)·2024

Search research articles

Related Experiment Video

Updated: May 29, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

Postmarketing surveillance.

Vera Vlahović-Palčevski¹, Dirk Mentzer

¹Department for Clinical Pharmacology, University of Rijeka Medical School, University Hospital Center Rijeka, Krešimirova 42, 51000 Rijeka, Croatia. vvlahovic@inet.hr

Handbook of Experimental Pharmacology

|September 2, 2011

Summary

Postmarketing drug surveillance monitors medications after clinical trials, focusing on adverse drug reactions (ADRs). Paediatric pharmacovigilance requires special attention due to age-related differences in drug effects and safety.

More Related Videos

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Related Experiment Videos

Last Updated: May 29, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Area of Science:

Pharmacovigilance
Drug Safety Monitoring
Paediatric Pharmacology

Background:

Postmarketing drug surveillance monitors medications post-approval.
It detects previously unrecognized drug effects in diverse patient populations.
Adverse drug reactions (ADRs) are a primary focus of surveillance.

Purpose of the Study:

To summarize and discuss key issues in paediatric pharmacovigilance.
To highlight the importance of tailored drug safety monitoring in children.
To address challenges in paediatric drug use and formulation.

Main Methods:

Review of postmarketing surveillance principles.
Analysis of paediatric pharmacovigilance requirements.
Discussion of factors influencing paediatric drug safety.

Main Results:

Postmarketing surveillance is crucial for identifying rare or long-term ADRs.
Paediatric populations exhibit unique responses to medications.
Heterogeneity in children necessitates customized pharmacovigilance strategies.

Conclusions:

Paediatric pharmacovigilance demands specialized approaches.
Age-related differences impact drug benefit-risk balance in children.
Effective drug safety monitoring in paediatrics requires consideration of developmental stages.